(Q43689374)

25 November 2017

Multifocal ERG and full-field ERG in patients on long-term vigabatrin medication (English)

1 reference

25 November 2017

Ponjavic V

1

1 reference

PubMed ID

11475366

25 November 2017

Andréasson S

series ordinal

2

1 reference

25 November 2017

1 January 2001

1 reference

Documenta Ophthalmologica

25 November 2017

1 reference

25 November 2017

102

1 reference

25 November 2017

63-72

1 reference

25 November 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1017589301855

25 November 2017

0 references

cites work

Effects of long-term vigabatrin on somatosensory-evoked potentials in epileptic patients

1 reference

12 December 2020

Symptomatic and asymptomatic visual loss in patients taking vigabatrin.

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing.

1 reference

12 December 2020

Visual field defects associated with vigabatrin therapy

1 reference

12 December 2020

Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions

1 reference

12 December 2020

Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin

1 reference

12 December 2020

Phenotypes in three Swedish families with X-linked retinitis pigmentosa caused by different mutations in the RPGR gene

1 reference

12 December 2020

The field topography of ERG components in man—I. The photopic luminance response

1 reference

12 December 2020

The influence of established and new antiepileptic drugs on visual perception. 1. A placebo-controlled, double-blind, single-dose study in healthy volunteers

1 reference

12 December 2020

Effects of vigabatrin on evoked potentials in epileptic patients

1 reference

12 December 2020

Evoked potential monitoring of vigabatrin patients

1 reference

12 December 2020

Imaging localized retinal dysfunction with the multifocal electroretinogram

1 reference

12 December 2020

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Manufacturers have started several studies

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Asymptomatic as well as symptomatic defects occur with vigabatrin

1 reference

12 December 2020

Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy

1 reference

12 December 2020

Severe persistent visual field constriction associated with vigabatrin. Four possible explanations exist.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1017589301855

1 reference

PubMed ID

11475366

Dimensions Publication ID

25 November 2017

0 references

1 reference

PubMed ID

11475366